Curable sexually transmitted infections (STIs) contribute to adverse maternal and neonatal outcomes. Syndromic management is standard care in South Africa. We evaluated prevalence, symptomology, and correlates of curable STIs, among pregnant women in Eastern Cape, South Africa.
Methods
We conducted a cross-sectional analysis using baseline data from a randomized controlled trial of pregnant women attending their first antenatal care visit at public clinics in Buffalo City Municipality (2021–2024). Participants were tested for Chlamydia (C.) trachomatis, Neisseria (N.) gonorrhoeae, Trichomonas (T.) vaginalis using GeneXpert point-of-care tests and for syphilis using Alere Determine TP rapid test. Symptoms were self-reported and clinically-observed. Adjusted prevalence ratios were estimated using Poisson regression models with robust standard errors.
Results
Among 1491 participants (median age: 28 years (IQR: 24–33); gestational age: 13 weeks (IQR: 8–18); HIV prevalence: 30%), STI prevalence was 27.6% (95% CI: 25.3–29.9): C. trachomatis 14.7%, N. gonorrhea 5%, T. vaginalis 10.2%, syphilis 3.4%. Women with HIV had higher STI prevalence (32.8% vs 25.3%, p = .003), particularly for T. vaginalis (17% vs 7.3%, p < .001); 20.1% of women with C. trachomatis, N. gonorrhea, and/or T. vaginalis were symptomatic, and 63% of symptomatic women tested STI-negative. Younger age, lower education, multiple sex partners and unknown HIV-serostatus of partners were associated with increased STI prevalence.
Conclusion
We observed a high prevalence of STIs, particularly among women with HIV, with many asymptomatic cases; emphasizing the need for integrated point-of-care testing to ensure timely treatment, reduce antibiotic overuse, and improve maternal and neonatal outcomes.
FelskeLRCastilloEKuretV, et al.Comparing adverse neonatal and maternal outcomes of chlamydia, gonorrhoea, and syphilis infections and co-infections in pregnancy. Paediatr Perinat Epidemiol2022; 36(4): 556–565.
4.
HillAVPerez-PatronMTekweCD, et al.Chlamydia trachomatis is associated with medically indicated preterm birth and preeclampsia in young pregnant women. Sex Transm Dis2020; 47(4): 246–252.
5.
TaylorBDAdekanmbiVZhangY, et al.The impact of Neisseria gonorrhoeae mono- and coinfection on adverse pregnancy outcomes. Open Forum Infect Dis2023; 10(5): ofad220.
6.
MannJRMcDermottSGillT. Sexually transmitted infection is associated with increased risk of preterm birth in South Carolina women insured by Medicaid. J Matern Fetal Neonatal Med2010; 23(6): 563–568.
7.
SilverBJGuyRJKaldorJM, et al.Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sex Transm Dis2014; 41(6): 369–376.
8.
GalvinSRCohenMS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol2004; 2(1): 33–42.
9.
TebitDMNdembiNWeinbergA, et al.Mucosal transmission of human immunodeficiency virus. Curr HIV Res2012; 10(1): 3–8.
10.
NyembaDCMedina-MarinoAPetersRPH, et al.Prevalence, incidence and associated risk factors of STIs during pregnancy in South Africa. Sex Transm Infect2021; 97(5): 375–381.
11.
Joseph DaveyDLNyembaDCGombaY, et al.Prevalence and correlates of sexually transmitted infections in pregnancy in HIV-infected and- uninfected women in Cape Town, South Africa. PLoS One2019; 14(7): e0218349.
12.
GovenderVMoodleyDNaidooM, et al.High incidence of asymptomatic genital tract infections in pregnancy in adolescent girls and young women: need for repeat aetiological screening. Sex Transm Infect2023; 99(7): 482–488.
13.
MudauMPetersRPDe VosL, et al.High prevalence of asymptomatic sexually transmitted infections among human immunodeficiency virus-infected pregnant women in a low-income South African community. Int J STD AIDS2018; 29(4): 324–333.
14.
PriceCMPetersRPSteynJ, et al.Prevalence and detection of Trichomonas vaginalis in HIV-infected pregnant women. Sex Transm Dis2018; 45(5): 332–336.
MlisanaKNaickerNWernerL, et al.Editor’s choice: symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis2012; 206(1): 6–14.
Medina-MarinoAClearySMuznyCA, et al.Sexually transmitted infection screening to prevent adverse birth and newborn outcomes: study protocol for a randomized-controlled hybrid-effectiveness trial. Trials2022; 23: 441.
21.
Von ElmEAltmanDGEggerM, et al.The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol2008; 61(4): 344–349.
22.
HarrisPATaylorRPayneJ, et al.Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform2009; 42(2): 377–381.
TennantPWGMurrayEJArnoldKF, et al.Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations. Int J Epidemiol2021; 50(2): 620–632.
26.
WynnARamogola-MasireDGaolebaleP, et al.Prevalence and correlates of sexually transmitted infections among pregnant women, gaborone, Botswana, 2016. Open Forum Infect Dis2016; 3(suppl_1): 1316.
27.
MussaAWynnARyanR, et al.Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection and associated factors among asymptomatic pregnant women in Botswana. Int J STD AIDS2023; 34(7): 448–456.
28.
MashaSCWahomeEVaneechoutteM, et al.High prevalence of curable sexually transmitted infections among pregnant women in a rural county hospital in Kilifi, Kenya. PLoS One2017; 12(3): e0175166, Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375155/
29.
ZenebeMHMekonnenZLohaE, et al.Prevalence, risk factors and association with delivery outcome of curable sexually transmitted infections among pregnant women in Southern Ethiopia. PLoS One2021; 16(3): e0248958.
30.
Joseph-DaveyDde VouxAHlatshwayoL, et al.Prevention of congenital syphilis within antenatal PrEP services in South Africa: missed opportunities. Lancet Infect Dis2024; 24(6): 571–572.
31.
HoqueMHoqueMEvan HalG, et al.Prevalence, incidence and seroconversion of HIV and Syphilis infections among pregnant women of South Africa. S Afr J Infect Dis2021; 36(1): 296.
32.
OnyangungaOANaickerTMoodleyJ. A clinical audit of maternal syphilis in a regional hospital in KwaZulu-Natal, South Africa. J Infect Dis2020; 35(1): 115.
ManyahiJJulluBSAbuyaMI, et al.Prevalence of HIV and syphilis infections among pregnant women attending antenatal clinics in Tanzania. BMC Public Health2015; 15: 501.
35.
KurewaNEMapingureMPMunjomaMW, et al.The burden and risk factors of Sexually Transmitted Infections and Reproductive Tract Infections among pregnant women in Zimbabwe. BMC Infect Dis2010; 10(1): 127.
36.
JarolimovaJPlattLRCurtisMR, et al.Curable sexually transmitted infections among women with HIV in sub-Saharan Africa. AIDS2022; 36(5): 697–709.
37.
Dionne-OdomJKhanMJJaukVC, et al.HIV status and other risk factors for prevalent and incident sexually transmitted infection during pregnancy (2000-2014). Infect Dis Obstet Gynecol2019; 2019(1): 6584101.
38.
KalichmanSCPellowskiJTurnerC. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect2011; 87(3): 183–190.
39.
VandepitteJBukenyaJWeissHA, et al.HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda. Sex Transm Dis2011; 38(4): 316–323.
40.
OstrachBSingerM. At special risk: biopolitical vulnerability and HIV/STI syndemics among women. Health Sociol Rev2012; 21(3): 258–271.
41.
BlackstockOJFrewPBotaD, et al.Perceptions of community HIV/STI risk among U.S women living in areas with high poverty and HIV prevalence rates. J Health Care Poor Underserved2015; 26(3): 811–823.
GattiFADACeolanEGrecoFSR, et al.The prevalence of trichomoniasis and associated factors among women treated at a university hospital in southern Brazil. PLoS One2017; 12(3): e0173604.
44.
DavisADasguptaAGoddard-EckrichD, et al.Trichomonas vaginalis and human immunodeficiency virus coinfection among women under community supervision: a call for expanded T. vaginalis screening. Sex Transm Dis2016; 43(10): 617–622.
45.
McClellandRSSangareLHassanWM, et al.Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis2007; 195(5): 698–702.
46.
BabalolaCMPetersRPHMukomanaF, et al.A call to standardize the definition and method of assessing women for vaginal discharge syndrome in pregnancy. Open Forum Infect Dis2023; 10(4): ofad157.
47.
MorikawaEMudauMOlivierD, et al.Acceptability and feasibility of integrating point-of-care diagnostic testing of sexually transmitted infections into a South African antenatal care program for HIV-infected pregnant women. Infect Dis Obstet Gynecol2018; 2018: 3946862.
48.
WynnARamogola-MasireDGaolebaleP, et al.Acceptability and feasibility of sexually transmitted infection testing and treatment among pregnant women in gaborone, Botswana, 2015. BioMed Res Int2016; 2016: 1251238.
49.
BadmanSGVallelyLMTolimanP, et al.A novel point-of-care testing strategy for sexually transmitted infections among pregnant women in high-burden settings: results of a feasibility study in Papua New Guinea. BMC Infect Dis2016; 16(1): 250.
50.
MdingiMMPetersRPHGigiR, et al.Same-day treatment following point-of-care sexually transmitted infection testing in different healthcare settings in South Africa. Clin Infect Dis2022; 76(9): 1699–1700.
51.
JenningsJMTaylorRBSalhiRA, et al.Neighborhood drug markets: a risk environment for bacterial sexually transmitted infections among urban youth. Soc Sci Med2012; 74(8): 1240–1250.
52.
AdimoraAASchoenbachVJ. Social context, sexual networks, and racial disparities in rates of sexually transmitted infections. J Infect Dis2005; 191(s1): 115–122.
53.
JenningsJMTaylorRIannacchioneVG, et al.The available pool of sex partners and risk for a current bacterial sexually transmitted infection. Ann Epidemiol2010; 20(7): 532–538.
54.
RamjeeGWandH. Geographical clustering of high risk sexual behaviors in “hot-spots” for HIV and sexually transmitted infections in kwazulu-natal, South Africa. AIDS Behav2014; 18(2): 317–322.
